Meta-analysiscited by the Tayebat archivefull text checked A-SOD-08 in-depth review

Sugary drinks, diet drinks, juice and diabetes

Consumption of sugar sweetened beverages, artificially sweetened beverages, and fruit juice and incidence of type 2 diabetes: systematic review, meta-analysis, and estimation of population attributable fraction.

Overview

Imamura F et al.. BMJ 2015 · PMID 26199070 · DOI 10.1136/bmj.h3576

Each daily sugary drink was linked with 13-18% more diabetes; diet drinks and juice also showed (possibly biased) links.

Does the study support the specific claim? Yes · Methodological quality: high

Original publication

Plain-language summary

Study explained simply
What did the researchers want to find out?

Are SSB, ASB and fruit juice associated with T2D independently of adiposity?

How was the study done?

Systematic review and random-effects meta-analysis of prospective cohorts; PAF estimation (US, UK).

How many people, animals or samples were studied?

17 cohorts; 38,253 cases; 10,126,754 person-years; Adults without diabetes

What was actually found?

Per serving/day: SSB +18% (9-28%; I2 89%) and +13% (6-21%) after adiposity adjustment; ASB +25% and +8% (publication bias and residual confounding indicated); fruit juice +5% (-1 to 11%) and +7% (1-14%). PAF: 8.7% USA, 3.6% UK.

How large was the observed effect?

+18% per serving (+13% adiposity-adjusted)

What do the results mean in everyday life?

Neither diet drinks nor juice are proven healthier alternatives to sugary drinks.

What are the study's limitations?

High heterogeneity; observational studies; protocol not registered; ASB and juice results likely biased

What does it say about Elawady's specific claim?

Supports C-SOD-01; mixed for C-SOD-10; limits C-SUG-06 (juice association).

Do the results apply to Germany and Europe?

High (UK PAF estimated).

What can explicitly not be concluded from this study?

Causation; that diet drinks or juice cause diabetes; diet-drink effects on mortality

Scientific in-depth review

1. Full reference

Authors
Imamura F, O'Connor L, Ye Z, Mursu J, Hayashino Y, Bhupathiraju SN, Forouhi NG
Journal
BMJ
Year
2015
Identifier
PMID 26199070 DOI 10.1136/bmj.h3576 · PMC4510779
Verification
verified – PubMed E-utilities efetch, 2026-10-25
Retracted
no
Corrections
none
Extent checked
full text
Conflicts of interest and funding

Medical Research Council Epidemiology Unit Core Support (MC_UU_12015/5); one author AHA postdoctoral fellowship. Authors declare no competing interests; sponsor had no role. No included study was industry funded.

2. Research question

Are SSB, ASB and fruit juice associated with T2D independently of adiposity?

3. Study design and population

Study design
Meta-analysis – Systematic review (PRISMA; protocol not registered, available on request) and random-effects dose-response meta-analysis of prospective cohorts, with Cochrane-based risk-of-bias assessment, GRADE, calibration for measurement error and publication bias, and population attributable fraction estimation (USA, UK)
Population

Adults without diabetes

Country

Multinational; PAF for USA and UK

Period

Searches 31 May 2013, updated 10 February 2014 (PubMed, Embase, Ovid, Web of Knowledge; no language or date limits); PAF for 2010-2020

Sample size

17 cohorts (21 articles of 16 cohorts plus 1 unpublished); 38,253 cases over 10,126,754 person-years; PAF based on 4729 US (NHANES 2009-10) and 1932 UK (NDNS 2008-12) adults

Inclusion and exclusion criteria

Prospective studies of adults >=18 years free of diabetes, assessing beverage consumption and incident T2D, mean follow-up >=2 years

4. Methods and endpoints

Exposure / intervention

Per one serving/day (also per 250 mL/day) of SSB, ASB and 100% fruit juice

Comparator

Lower intake (dose-response per serving/day)

Endpoints

Incident T2D

Statistical methods

Random-effects meta-analysis (prespecified); I2; estimates before/after adiposity adjustment and crude; calibration for within-person dietary variation and self-reported diabetes; meta-regression; Egger test, contour-enhanced funnel plots, trim and fill; influence analysis; simulation of residual confounding by imperfectly measured adiposity; GRADE; PAF with validated risk algorithms assuming causality

5. Actual results

Results

Per serving/day, before/after adiposity adjustment: SSB RR 1.18 (95% CI 1.09-1.28; I2 89%) and 1.13 (1.06-1.21; I2 79%); ASB 1.25 (1.18-1.33; I2 70%) and 1.08 (1.02-1.15; I2 64%); fruit juice 1.05 (0.99-1.11) and 1.07 (1.01-1.14). Adjustment for confounders attenuated SSB from 1.25 to 1.18 and ASB from 1.48 to 1.25. Calibration for within-person variation strengthened SSB to 1.28 (1.12-1.46). ASB after publication-bias calibration 1.22 (0.98-1.52; n.s.). Residual-confounding simulation (r=0.80 for adiposity): SSB 1.20 (1.04-1.38), ASB 1.01 (0.81-1.25), fruit juice 1.12 (1.03-1.22). Fruit juice null in studies with objective T2D ascertainment (1.08, 0.97-1.20) and repeated diet measures (0.98, 0.86-1.11). GRADE: SSB moderate; ASB and fruit juice low. PAF (adiposity-adjusted): USA 8.7% (3.9-12.9%), UK 3.6% (1.7-5.6%); adiposity-unadjusted 11.9% and 4.9%. No study was industry funded.

Absolute risks

Predicted 10-year T2D event rate 11.0% (USA, 20.9 million events) and 5.8% (UK, 2.6 million); attributable to SSB under causal assumption: 1.8 million (USA) and 79,000 (UK) adiposity-adjusted, 2.6 million and 126,000 unadjusted.

Authors' conclusion

Habitual SSB consumption associated with T2D independently of adiposity; ASB and fruit juice associations likely biased but neither are healthy alternatives.

6. Strengths

  • Four databases, no language limits, duplicate review and extraction
  • Formal risk-of-bias assessment (Cochrane NRSI-based, 7 domains) and GRADE
  • Adiposity-adjusted and unadjusted estimates; measurement-error calibration
  • Extensive sensitivity, publication-bias and residual-confounding analyses
  • PAF estimation with national data

7. Weaknesses

  • Protocol not registered
  • High heterogeneity for SSB (I2 79-89%)
  • Observational cohorts; residual confounding and reverse causation, especially for ASB (authors)
  • Dose-response partly derived from categorical estimates and ORs
  • PAF assumes causality and no change in lifestyle
  • Eligible cohorts excluded for lack of information
  • Bias assessment summarised by one author then discussed (subjectivity acknowledged)

8. Risk of bias

Orienting tool
AMSTAR 2
Type of assessment
structured assessment based on the full text by a single reviewer (no formal double review)
Full formal assessment
no
Overall risk of bias
low
Rationale

High-quality review; only non-critical weakness in protocol registration. Confidence in SSB estimate moderate (GRADE), ASB/fruit juice low. Overlaps with A-SOD-01 primary studies (not independent confirmation). Structured single-reviewer judgement from full text; a formal assessment would require two independent reviewers and the protocol.

8. Risk of bias
DomainJudgementRationale
Item 2 protocol established before review (critical)some concernsProtocol exists (available on request) but not registered.
Item 4 comprehensive search (critical)lowFour databases plus hand search, no language/date limits, author contact for unpublished data.
Item 5/6 duplicate selection and extractionlowFull texts reviewed in duplicate; standardised duplicate extraction.
Item 7 excluded studies justified (critical)lowSupplementary table S1 lists cohorts not meeting criteria.
Item 9 risk of bias of included studies (critical)lowCochrane NRSI-based tool with seven domains; studies with potential bias identified.
Item 11 appropriate meta-analytic methods (critical)lowRandom effects, dose-response, calibration, meta-regression.
Item 13 RoB considered in interpretation (critical)lowGRADE ratings and explicit downgrading of ASB and fruit-juice evidence.
Item 15 publication bias (critical)lowEgger, contour-enhanced funnel and trim-and-fill with calibrated estimates.
Item 16 COIlowFunding and COI reported; industry funding of primary studies checked.

Full-text review (25 October 2026): Added search/selection and RoB methods, confounder attenuation, measurement-error calibration (SSB 1.28), ASB after publication-bias calibration (1.22, n.s.) and residual-confounding simulation (1.01), fruit-juice subgroup null findings, GRADE ratings, PAF details, funding; AMSTAR 2 items added, overall unchanged (low).

9. Assessment of the statistical interpretation

SSB: robust, moderate-certainty association of about 13-18% per daily serving (up to 28% after measurement-error calibration); PAF of 4-13% (USA) under causal assumptions. ASB: association largely explained by residual confounding/publication bias (1.01 in simulation; 1.22, n.s., after publication-bias calibration). Fruit juice: unstable, null in objectively ascertained studies.

10. Relevance to the specific claim

Supports C-SOD-01; mixed for C-SOD-10; limits C-SUG-06 (juice association).

11. Independent contrary findings

None.

12. Transferability to Germany and Europe

High (UK PAF estimated).

13. Overall methodological judgement

High-quality meta-analysis; strong support for the SSB-diabetes association (moderate certainty) and weak, probably biased evidence for ASB and fruit juice.

Multidimensional assessment
Multidimensional assessment
Authenticity of the sourceverified
Methodological qualityhigh
Risk of biaslow
Precision of resultsmoderate
Directnessdirect
Reproducibilityreplicated
Consistency with the overall evidenceconsistent
Regional transferabilityhigh
Adequacy of the interpretation (by the archive)taken out of context

14. Open questions

Causality for ASB and juice.

15. Linked fact checks

Use by the Tayebat archive

Note: according to the archive, the studies were compiled by the archive operators. Whether Dr. Elawady himself cited this study is not established.

What the archive says about the study

(Narrative) A newer BMJ meta-analysis 'raised the number' to an 18% jump in diabetes risk for every daily serving.

A. What was actually studied?

SSB, ASB, juice and T2D.

B. What did the authors find?

SSB +18% per serving (13% adjusted for adiposity); ASB and juice associations likely biased.

C. What conclusions do the authors themselves draw?

SSB associated with T2D; ASB and juice not healthy alternatives.

D. What does the archive derive from it?

Presents 18% per serving as an increase over the earlier 26% estimate.

E. Is this derivation scientifically justified?

Not justified as framed: 18% per serving and 26% highest vs lowest (A-SOD-01) are different metrics, not an increase; the archive omits the adiposity-adjusted 13%, the low-certainty and probably biased ASB result, and the fruit-juice findings.

Adequacy of the interpretation (by the archive)
taken out of context